COMPANY ANNOUNCEMENT
Pharm D Solutions, LLC Issues Voluntary Nationwide Recall of All Sterile Compounded Drugs Due to a Potential Lack of Sterility Assurance
This recall has been completed and FDA has terminated this recall.
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.
Read Announcement View Product PhotosSummary
- Company Announcement Date:
- FDA Publish Date:
- Product Type:
- Drugs
Generic Drugs - Reason for Announcement:
-
Recall Reason DescriptionLack of sterility assurance
- Company Name:
- Pharm D Solutions, LLC
- Brand Name:
-
Brand Name(s)Pharm D Solutions
- Product Description:
-
Product DescriptionSterile Compounded Drug Products
Company Announcement
FOR IMMEDIATE RELEASE – Houston, Texas, Pharm D Solutions, LLC is voluntarily recalling all sterile compounded drug products within expiry to the consumer level. These drug products are being voluntarily recalled due to concerns that practices at the pharmacy have the potential to pose a risk of contamination to products that are intended to be sterile. These concerns arose following a routine inspection of the pharmacy by FDA.
Administration of a non-sterile product that is intended to be sterile by subcutaneous, intramuscular, intravenous or ocular routes of administration may result in serious injury or death. To date, Pharm D Solutions, LLC is not aware of any adverse events related to this recall. This voluntary recall is being conducted out of an abundance of caution and to promote patient safety, which is the pharmacy's highest priority.
The recall encompasses all compounded sterile drug products, within expiry, that were dispensed within from October 24, 2018 to May 21,2019. The sterile drug products subject to this recall were distributed nationwide and directly to customers and/or medical facilities. The recall does not affect the pharmacy's non-sterile compounded products or retail pharmacy operations.
The pharmacy has notified potentially affected customers of the voluntary recall via U.S. Mail and direct outreach. Customers who have received sterile compounded products subject to the voluntary recall should stop using and return the product to the pharmacy for a full refund.
Consumers with questions regarding this recall can contact Pharm D Solutions, LLC by calling Luis R DeLeon or Carlos DeLeon at 1-844-263-6846, Monday through Friday between 10:00 a.m. and 4:30 p.m., CST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these drug products.
Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Complete and submit the report Online: http://www.fda.gov/medwatch/report.htm
- Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332- 1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
PRODUCT | LOT NUMBER |
---|---|
TESTOSTERONE CYPIONATE GS 200 MG/ML 10 ML | 10242018:70/A |
TESTOSTERONE 200 MG/ML GRAPESEED OIL 30 ML 200 MG/ML | 10242018:70/B |
HUMAN CHORIONIC GONADOTROPIN 3000 IU LYOPHILIZED | 10292018:21 |
TESTOSTERONE 200 MG/ML GRAPESEED OIL 30 ML 200 MG/ML | 10302018:63/A |
TESTOSTERONE CYPIONATE GS 200 MG/ML 5 ML | 10242018:70/P |
BACTERIOSTATIC WATER FOR INJECTION 10 ML | 11292018:75 |
SERMORELIN/GHRP-2/GHRP-6 3 MG/3 MG/3 MG LYOPHILIZED | 12062018:17 |
SERMORELIN / IPAMORELIN 18 MG/ 15 MG LYOPHILIZED | 12262018:69 |
BACTERIOSTATIC WATER FOR INJECTION 10 ML 10 ML | 01022019:70 |
SERMORELIN / IPAMORELIN 18 MG/ 15 MG LYOPHILIZED | 01072019:12 |
SERMORELIN / IPAMORELIN 18 MG/ 15 MG LYOPHILIZED | 01072019:88 |
HUMAN CHORIONIC GONADOTROPIN 5000 IU LYOPHILIZED | 01082019:88 |
LIPO MIC-12 METHIONINE/INOSITOL/CHOLINE/METHYLCOBALAMIN 10 ML 15 MG/50 MG/100 MG/1 MG INJECTABLE | 01172019:69 |
HUMAN CHORIONIC GONADOTROPIN 12000 IU LYOPHILIZED | 01232019:86 |
LIPO MIC-12 METHIONINE/INOSITOL/CHOLINE/METHYLCOBALAMIN 10 ML 15 MG/50 MG/100 MG/1 MG INJECTABLE | 01252019:94 |
LIPO MIC-12 METHIONINE/INOSITOL/CHOLINE/METHYLCOBALAMIN 10 ML 15 MG/50 MG/100 MG/1 MG INJECTABLE | 01282019:55 |
SERMORELIN / IPAMORELIN 18 MG/ 15 MG LYOPHILIZED | 01292019:69 |
LIPO MIC-12 METHIONINE/INOSITOL/CHOLINE/METHYLCOBALAMIN 10 ML 15 MG/50 MG/100 MG/1 MG INJECTABLE | 01312019:86 |
TESTOSTERONE CYP/PRO 200 MG/10 MG /ML 10 ML INJECTABLE | 01312019:02 |
NANDROLONE GS 10 ML 200 MG/ML INJECTABLE | 01312019:34 |
BACTERIOSTATIC WATER FOR INJECTION 10 ML 10 ML INJECTABLE | 02042019:04 |
HUMAN CHOIONIC GONADOTROPIN 10,000 IU LYOPHILIZED | 02052019:42 |
TESTOSTERONE CYP/PRO 200 MG/10 MG /ML 10 ML INJECTABLE | 02072019:45/A |
SERMORELIN/GHRP-2/GHRP-6 9 MG/9 MG/9 MG LYOPHILIZED | 02182019:79 |
LIPO MIC-12 METHIONINE/INOSITOL/CHOLINE/METHYLCOBALAMIN 10 ML 15 MG/50 MG/100 MG/1 MG INJECTABLE | 02202019:53/A |
TESTOSTERONE CYPIONATE GS 200 MG/ML 10 ML INJECTABLE | 02262019:49/A |
BACTERIOSTATIC WATER FOR INJECTION 10 ML 10 ML INJECTABLE | 03042019:94 |
SERMORELIN/GHRP-2 9 MG-6 MG LYOPHILIZED | 03052019:43 |
HUMAN CHORIONIC GONADOTROPIN 5000 IU LYOPHILIZED | 03182019:58 |
LIPO MIC-12 METHIONINE/INOSITOL/CHOLINE/METHYLCOBALAMIN 10 ML 15 MG/50 MG/100 MG/1 MG INJECTABLE | 04012019:67/A |
LIPO MIC-12 METHIONINE/INOSITOL/CHOLINE/METHYLCOBALAMIN 10 ML 15 MG/50 MG/100 MG/1 MG INJECTABLE | 04022019:47/A |
B-COMPLEX B-1,B-6,B-3,B-12,B-5 100,2.54 INJECTABLE 10 ml | 04032019:23 |
LIPO MIC-12 METHIONINE/INOSITOL/CHOLINE/METHYLCOBALAMIN 10 ML 15 MG/50 MG/100 MG/1 MG INJECTABLE | 04042019:04/A |
SERMORELIN / IPAMORELIN 18 MG/ 15 MG LYOPHILIZED | 04042019:61 |
SERMORELIN/GHRP-2 9 MG-6 MG LYOPHILIZED | 04042019:15 |
HUMAN CHORIONIC GONADOTROPIN 12000 IU LYOPHILIZED | 04042019:86 |
LIPO MIC-12 METHIONINE/INOSITOL/CHOLINE/METHYLCOBALAMIN 10 ML 15 MG/50 MG/100 MG/1 MG INJECTABLE | 04082019:38/A |
SERMORELIN/GHRP-2/GHRP-6 9 MG/9 MG/9 MG LYOPHILIZED | 04162019:86 |
SERMORELIN / IPAMORELIN 18 MG/ 15 MG LYOPHILIZED | 04162019:48 |
SERMORELIN/GHRP-2 9 MG-6 MG LYOPHILIZED | 04172019:08 |
LIPO MIC-12 METHIONINE/INOSITOL/CHOLINE/METHYLCOBALAMIN 10 ML 15 MG/50 MG/100 MG/1 MG INJECTABLE | 04302019:49/A |
SERMORELIN / IPAMORELIN 18 MG/ 15 MG LYOPHILIZED | 04302019:70 |
IPAMORELIN ACETATE 9 MG INJECTABLE | 05022019:50 |
TRIMIX PAPAVERINE/PHENTOLAMINE/ALPROSTADIL 30 MG / 1 MG /10 MCG/ML INJECTABLE | 05022019:90 |
SERMORELIN / IPAMORELIN 18 MG/ 15 MG LYOPHILIZED | 05022019:34 |
SERMORELIN/GHRP-2 9 MG-6 MG LYOPHILIZED | 05022019:47 |
SERMORELIN/GHRP-2/GHRP-6 9 MG/9 MG/9 MG LIQUID | 05032019:29 |
LIPO MIC-12 METHIONINE/INOSITOL/CHOLINE/METHYLCOBALAMIN 10 ML 15 MG/50 MG/100 MG/1 MG INJECTABLE | 05062019:09 |
IPAMORELIN ACETATE 9 MG INJECTABLE | 05082019:91 |
SERMORELIN/GHRP-2 9 MG/9 MG LYOPHILIZED | 05082019:92 |
SERMORELIN/GHRP-2 9 MG-6 MG LYOPHILIZED | 05082019:78 |
Company Contact Information
- Consumers:
- Luis R De Leon
- 713-790-1693